Drug information for BEPREVE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION/DROPS; OPHTHALMIC
1.5%
Prescription
(Reference Drug)
BEPOTASTINE BESILATE
bepotastine besilate
ISTA PHARMS
22288
2009-10-21 Review
2009-10-21 Summary Review
2009-09-18 Label
2009-09-16 Letter
Drug Adverse Effects information for BEPREVE
Role code
Indications
Reaction
# Reports
PS
BLEPHARITIS
DRUG HYPERSENSITIVITY
1
PS
BLEPHARITIS
LIP SWELLING
1
PS
BLEPHARITIS
PRURITUS
1
PS
BLEPHARITIS
RASH ERYTHEMATOUS
1
PS
BLEPHARITIS
SWOLLEN TONGUE
1
C
ASTHMA
BURNING SENSATION
1
C
ASTHMA
DRY EYE
1
C
ASTHMA
OEDEMA PERIPHERAL
1
C
ASTHMA
TOOTH EROSION
1
C
HYPERSENSITIVITY
ERYTHEMA OF EYELID
1
C
HYPERSENSITIVITY
EYELID OEDEMA
1
C
HYPERSENSITIVITY
EYELIDS PRURITUS
1
C
MADAROSIS
ERYTHEMA OF EYELID
1
C
MADAROSIS
EYELID OEDEMA
1
C
MADAROSIS
EYELIDS PRURITUS
1
C
MULTIPLE SCLEROSIS
ALANINE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
BLOOD CREATININE INCREASED
1
C
MULTIPLE SCLEROSIS
BLOOD TRIGLYCERIDES INCREASED
1
C
MULTIPLE SCLEROSIS
GRANULOCYTE COUNT INCREASED
1
C
MULTIPLE SCLEROSIS
HEADACHE
1
C
MULTIPLE SCLEROSIS
HIGH DENSITY LIPOPROTEIN INCREASED
1
C
MULTIPLE SCLEROSIS
LIVER FUNCTION TEST ABNORMAL
1
C
MULTIPLE SCLEROSIS
LYMPHOCYTE COUNT INCREASED
1
C
MULTIPLE SCLEROSIS
MEAN CELL HAEMOGLOBIN DECREASED
1
C
MULTIPLE SCLEROSIS
UROBILINOGEN URINE INCREASED
1
Ads by Google